Changes in cigarette smoking behavior among breast cancer and unaffected women – A prospective study in the MARIE cohort

Gali, Kathleen; Bokemeyer, Frederike; Behrens, Sabine; Möhl, Annika; Obi, Nadia; Becher, Heiko; Chang‐Claude, Jenny

doi:10.1016/j.canep.2022.102282

Cited by 2 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study focused on female breast cancer patients revealed that merely 17% of those who smoked reported cutting down or quitting smoking within a year of undergoing breast cancer treatment. 17 In this research, 54,614 women diagnosed with breast cancer participated, with 1687 being smokers and 52,927 non-smokers. Table 1 displays a comparison of baseline characteristics between women who smoked and those who did not among the breast cancer patients.…”

Section: Tobaccomentioning

confidence: 99%

Exploring human mammaglobin: as a possible diagnostic and prognostic indicator in breast cancer tissue

Alnefaie,

Almutairi,

Alsamiri

et al. 2024

Int J Community Med Public Health

View full text Add to dashboard Cite

Breast cancer is a major global health issue, with high diagnosis rates worldwide, especially in less developed areas, leading to significant mortality rates. This review focuses on the molecular characteristics of breast cancer, emphasizing the role of human mammaglobin-A (hMAM-A) as a diagnostic and prognostic marker. hMAM-A, a dimeric protein from the secretoglobin family, is produced exclusively by breast tissue and shows elevated levels in breast cancer cases, making it a highly accurate marker for disease detection. The review also examines various factors influencing breast cancer, such as age, tobacco use, menopausal status, and hormone replacement therapy (HRT). Younger age at diagnosis is associated with poorer outcomes, highlighting the importance of early detection. Tobacco smoke increases mortality rates in breast cancer patients. Menopausal status affects molecular subtypes and risk factors, impacting treatment and prognosis. HRT has a complex relationship with breast cancer risk. The review concludes by discussing the need for novel biomarkers, including hMAM-A, to improve breast cancer diagnosis and management.

show abstract

Section: Tobaccomentioning

confidence: 99%